This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

reputable news agency

proofread

Statement outlines inequities in cardio-oncology care, research

Statement outlines inequities in cardio-oncology care, research

Inequities in cardio-oncology care and research are addressed in a scientific statement issued by the American Heart Association and published online June 28 in Circulation.

Daniel Addison, M.D., from Ohio State University, and colleagues defined the current state of evidence relating to disparities in cardio-oncology and proposed an integrated approach to mitigate disparities in the routine clinical setting.

The authors note that women seem to have higher rates of immune checkpoint inhibitor-related toxicities, with some unique cardiotoxic mechanisms identified in women. The risk for cardiotoxicity and with anticancer (targeted, immune, hormone) therapies is increased up to threefold for Black patients. Increased cardiotoxic risk is also seen in other racial and ethnic minority groups. Among Black patients, hypertension and other are disproportionately increased with chemotherapy.

Because many trials do not represent diverse populations well, caution should be exercised in interpretation of clinical trial data for cardiotoxic risk assessment. In , social determinants of health influence long-term cardiovascular risk and survival. Future directions for addressing cardio-oncology disparities include further investigation of sex-specific differences in cardiac toxicities, mechanisms underlying disparate cardiotoxic risk, strategies for improving representation in cancer , and implementation of personalized cardioprotection strategies.

"Conscientiously leveraging technology and designing trials with outcomes related to these issues in practice (considering feasibility and cost) will critically accelerate the field of cardio-oncology in the 21st century. With tangible goals, we can improve health inequities in cardio-oncology," the authors write.

One author disclosed ties to the pharmaceutical industry.

More information: Daniel Addison et al, Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart Association, Circulation (2023). DOI: 10.1161/CIR.0000000000001158

Journal information: Circulation

Copyright © 2023 HealthDay. All rights reserved.

Citation: Statement outlines inequities in cardio-oncology care, research (2023, July 6) retrieved 19 April 2024 from https://medicalxpress.com/news/2023-07-statement-outlines-inequities-cardio-oncology.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Black cancer patients 71% more likely to experience heart damage following chemotherapy treatment

1 shares

Feedback to editors